This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Corneal Disorders  • Ophthalmological Procedures, Other  • Transplantation, Other  • Articles for Residents  • Alert me on articles by topic

Berthold Seitz, MD, FEBO; Miklós D. Resch, MD; Ursula Schlötzer-Schrehardt, PhD; Carmen Hofmann-Rummelt, BS; Renate Sauer, MD; Friedrich E. Kruse, MD

Arch Ophthalmol. 2006;124:1487-1490.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In recent years, amniotic membrane (AM) transplantation (AMT) has been used increasingly to treat various types of ocular surface pathologies.¹ Diverse techniques of AMT have been proposed for corneal diseases. One or more layers of AM can be used as a patch, graft, or sandwich (combination of 1 graft and a patch)^2-3 (Figure 1). Despite a growing body of literature on clinical applications of AM, little is known about the pathology of human corneas after AMT.^4-5 We offer histopathological, immunohistochemical, and ultrastructural evidence of the corneal epithelial (CE) growth patterns in relation to the AM.

Figure appears in full text version. Figure 1. Schematic drawings of various techniques of amniotic membrane (AM) transplantation (in each instance the AM is used epithelial side up). A, Patch onlay, used for corneal diseases with nonhealing epithelial . . . [Full Text of this Article]

Methods


Report of Cases
Case 1

Case 2

Case 3

Comment

AUTHOR INFORMATION